Evidence map›Paper›PMID 32575117›Full record

ArticleThe Journal of clinical endocrinology and metabolism2020

Functional Characterization of TMEM127 Variants Reveals Novel Insights into Its Membrane Topology and Trafficking.

Shahida K Flores, Yilun Deng, Ziming Cheng, Xingyu Zhang, Sifan Tao, Afaf Saliba, Irene Chu, Nelly Burnichon, Anne-Paule Gimenez-Roqueplo, Exing Wang and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Update on the genetics of paragangliomas.Endocrine-related cancer · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Shahida K FloresDivision of Hematology and Medical Oncology, Department of Medicine, UT Health San Antonio.
Yilun DengDivision of Hematology and Medical Oncology, Department of Medicine, UT Health San Antonio.
Ziming ChengDivision of Hematology and Medical Oncology, Department of Medicine, UT Health San Antonio.
Xingyu ZhangDivision of Hematology and Medical Oncology, Department of Medicine, UT Health San Antonio.
Sifan TaoDivision of Hematology and Medical Oncology, Department of Medicine, UT Health San Antonio.
Afaf SalibaDivision of Hematology and Medical Oncology, Department of Medicine, UT Health San Antonio.
Irene ChuDivision of Hematology and Medical Oncology, Department of Medicine, UT Health San Antonio.
Nelly BurnichonAssistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Genetics Department, Paris, France.
Anne-Paule Gimenez-RoqueploAssistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Genetics Department, Paris, France.
Exing WangDepartment of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, Texas.
Ricardo C T AguiarDivision of Hematology and Medical Oncology, Department of Medicine, UT Health San Antonio.
Patricia L M DahiaDivision of Hematology and Medical Oncology, Department of Medicine, UT Health San Antonio.
The University of Texas Health Science Center at San Antonio · USCentral South University · CNInserm · FR

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Robin Jean Leach · 1991 to 2026
$59.1M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUM1TR004538 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ROBERT A CLARK, Kenneth M Hargreaves · 2023 to 2026
$22.3M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR002645 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2018 to 2022
$20.4M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthKL2TR001118 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, DOUGHERTY, DONALD M · 2013 to 2017
$3.4M
Cancer Biology Training ProgramT32CA148724 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Pei Wang, Feng-Chun Yang · 2011 to 2026
$3.3M
Oxidative stress and RNA methylationR01ES031522 · NIEHS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI AGUIAR, RICARDO C · 2020 to 2024
$1.9M
Interaction of the TMEM127 tumor suppressor with the mTORC1 lysosomal activating complexR01GM114102 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI DAHIA, PATRICIA LEAL · 2017 to 2021
$1.5M
Mechanisms of internalization and trafficking of the tumor suppressor and lysosomal membrane protein TMEM127F31GM131634 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FLORES, SHAHIDA KARINA · 2019 to 2019
$34k
Post-Translational Control of TET Function in LymphomaI01BX001882 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI AGUIAR, RICARDO C · 2013 to 2025
–
BLRD VA I01 BX001882NCATS NIH HHS KL2 TR001118NCATS NIH HHS UL1 TR001120NCATS NIH HHS UL1 TR002645NCATS NIH HHS UM1 TR004538NCI NIH HHS P30 CA054174NCI NIH HHS T32 CA148724NIEHS NIH HHS R01 ES031522NIGMS NIH HHS F31 GM131634NIGMS NIH HHS R01 GM114102
6 · The paper itself

Abstract

contextTMEM127 is a poorly known tumor suppressor gene associated with pheochromocytomas, paragangliomas, and renal carcinomas. Our incomplete understanding of TMEM127 function has limited our ability to predict variant pathogenicity. PURPOSE: To better understand the function of the transmembrane protein TMEM127 we undertook cellular and molecular evaluation of patient-derived germline variants.

designSubcellular localization and steady-state levels of tumor-associated, transiently expressed TMEM127 variants were compared to the wild-type protein using immunofluorescence and immunoblot analysis, respectively, in cells genetically modified to lack endogenous TMEM127. Membrane topology and endocytic mechanisms were also assessed.

resultsWe identified 3 subgroups of mutations and determined that 71% of the variants studied are pathogenic or likely pathogenic through loss of membrane-binding ability, stability, and/or internalization capability. Investigation into an N-terminal cluster of missense variants uncovered a previously unrecognized transmembrane domain, indicating that TMEM127 is a 4- transmembrane, not a 3-transmembrane domain-containing protein. Additionally, a C-terminal variant with predominant plasma membrane localization revealed an atypical, extended acidic, dileucine-based motif required for TMEM127 internalization through clathrin-mediated endocytosis.

conclusionWe characterized the functional deficits of several germline TMEM127 variants and identified novel structure-function features of TMEM127. These findings will assist in determining pathogenicity of TMEM127 variants and will help guide future studies investigating the cellular role of TMEM127.

Indexed as

MutationAdrenal Gland NeoplasmsAmino Acid SubstitutionCell MembraneGene Knockdown TechniquesGenetic Predisposition to DiseaseGerm-Line MutationHEK293 CellsHumansMembrane ProteinsMutagenesis, Site-DirectedParagangliomaPheochromocytomaProtein TransportTissue DistributionMembrane ProteinsTMEM127 protein, humanendocytic motifgermline variantparagangliomapheochromocytomaTMEM127transmembrane proteintumor suppressor genevariant classification

Identifiers

PMID32575117
PMCPMC7414969
OpenAlexW3037768839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.